Literature DB >> 6317891

Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.

D M Coen, D P Aschman, P T Gelep, M J Retondo, S K Weller, P A Schaffer.   

Abstract

Mutations in five phenotypically distinct mutants derived from herpes simplex virus type 1 strain KOS which lie in or near the herpes simplex virus DNA polymerase (pol) locus have been fine mapped with the aid of cloned fragments of mutant and wild-type viral DNAs to distinct restriction fragments of 1.1 kilobase pairs (kbp) or less. DNA sequences containing a mutation or mutations conferring resistance to the antiviral drugs phosphonoacetic acid, acyclovir, and arabinosyladenine of pol mutant PAAr5 have been cloned as a 27-kbp Bg+II fragment in Escherichia coli. These drug resistance markers have been mapped more finely in marker transfer experiments to a 1.1-kbp fragment (coordinates 0.427 to 0.434). In intratypic marker rescue experiments, temperature-sensitive (ts), phosphonoacetic acid resistance, and acyclovir resistance markers of pol mutant tsD9 were mapped to a 0.8-kbp fragment at the left end of the EcoRI M fragment (coordinates 0.422 to 0.427). The ts mutation of pol mutant tsC4 maps within a 0.3-kbp sequence (coordinates 0.420 to 0.422), whereas that of tsC7 lies within the 1.1-kbp fragment immediately to the left (coordinates 0.413 to 0.420). tsC4 displays the novel phenotype of hypersensitivity to phosphonoacetic acid; however, the phosphonoacetic acid hypersensitivity phenotype is almost certainly not due to the mutation(s) conferring temperature sensitivity. The ts mutation of mutant tsN20--which does not affect DNA polymerase activity--maps to a 0.5-kbp fragment at the right-hand end of the EcoRI M fragment (coordinates 0.445 to 0.448). The mapping of the mutations in these five mutants further defines the limits of the pol locus and separates mutations differentially affecting catalytic functions of the polymerase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317891      PMCID: PMC255447     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Authors:  P A Schaffer; V C Carter; M C Timbury
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

2.  Identification of the herpes simplex virus DNA polymerase gene.

Authors:  D J Purifoy; R B Lewis; K L Powell
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

3.  Physical and genetic analysis of the herpes simplex virus DNA polymerase locus.

Authors:  P Chartrand; C S Crumpacker; P A Schaffer; N M Wilkie
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

4.  Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form.

Authors:  D B Clewell; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

5.  Genetic analysis of temperature-sensitive mutants which define the gene for the major herpes simplex virus type 1 DNA-binding protein.

Authors:  S K Weller; K J Lee; D J Sabourin; P A Schaffer
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue.

Authors:  P Chartrand; N D Stow; M C Timbury; N M Wilkie
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

7.  Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.

Authors:  D Derse; K F Bastow; Y Cheng
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

8.  Metabolism of acyclovir in virus-infected and uninfected cells.

Authors:  P A Furman; P de Miranda; M H St Clair; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

Review 9.  Aranucleosides and aranucleotides in viral chemotherapy.

Authors:  T W North; S S Cohen
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

10.  Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.

Authors:  R W Honess; D H Watson
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

View more
  55 in total

1.  Identification, localization, and regulation of expression of the UL24 protein of herpes simplex virus type 1.

Authors:  Angela Pearson; Donald M Coen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  The conserved helicase motifs of the herpes simplex virus type 1 origin-binding protein UL9 are important for function.

Authors:  R Martinez; L Shao; S K Weller
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  The UL8 subunit of the herpes simplex virus helicase-primase complex is required for efficient primer utilization.

Authors:  G Sherman; J Gottlieb; M D Challberg
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Purification and characterization of UL9, the herpes simplex virus type 1 origin-binding protein.

Authors:  D S Fierer; M D Challberg
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 5.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

6.  Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis.

Authors:  C A Wu; N J Nelson; D J McGeoch; M D Challberg
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

7.  Translational regulation of herpes simplex virus DNA polymerase.

Authors:  D R Yager; A I Marcy; D M Coen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.

Authors:  J T Matthews; R D Carroll; J T Stevens; M L Haffey
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity.

Authors:  D K Klinedinst; M D Challberg
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates.

Authors:  J W Mellors; H Z Bazmi; R F Schinazi; B M Roy; Y Hsiou; E Arnold; J Weir; D L Mayers
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.